BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8866043)

  • 1. Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies.
    Yu Z; Schwartz JB; Sugita ET; Foehl HC
    Biopharm Drug Dispos; 1996 Aug; 17(6):521-40. PubMed ID: 8866043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of drug absorption rate in time-variant disposition by direct deconvolution using beta clearance correction and end-constrained non-parametric regression.
    Neelakantan S; Veng-Pedersen P
    Biopharm Drug Dispos; 2005 Nov; 26(8):353-70. PubMed ID: 16088968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical stability of pharmacokinetic deconvolution algorithms.
    Süverkrüp R; Bonnacker I; Raubach HJ
    J Pharm Sci; 1989 Nov; 78(11):948-54. PubMed ID: 2621580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of drug absorption from the gastrointestinal tract with the use of numeric deconvolution].
    Gröning R; Heun G
    Pharm Acta Helv; 1989; 64(3):71-5. PubMed ID: 2726986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extended point-area deconvolution approach for assessing drug input rates.
    Yeh KC; Holder DJ; Winchell GA; Wenning LA; Prueksaritanont T
    Pharm Res; 2001 Oct; 18(10):1426-34. PubMed ID: 11697468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-level time-domain decomposition based distributed method for numerical solutions of pharmacokinetic models.
    Liu L; Lai CH; Zhou SD; Xie F; Rui L
    Comput Biol Med; 2011 Apr; 41(4):221-7. PubMed ID: 21396631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an NLME-Stochastic Deconvolution Approach to Level A IVIVC Modeling.
    Kakhi M; Suarez-Sharp S; Shepard T; Chittenden J
    J Pharm Sci; 2017 Jul; 106(7):1905-1916. PubMed ID: 28341596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of numerical integration algorithms for the estimation of the area under the curve (AUC) in pharmacokinetic studies.
    Yu Z; Tse FL
    Biopharm Drug Dispos; 1995 Jan; 16(1):37-58. PubMed ID: 7711282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-definition mapping of neural activity using voltage-sensitive dyes.
    Cinelli AR
    Methods; 2000 Aug; 21(4):349-72. PubMed ID: 10964579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the use of accelerated infusions for the determination of pharmacokinetic linearity.
    Ward KW; Griffiths R; Levy MA; Smith BR
    J Pharmacol Exp Ther; 2000 May; 293(2):468-79. PubMed ID: 10773017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population one-compartment pharmacokinetic analysis with missing dosage data.
    Soy D; Beal SL; Sheiner LB
    Clin Pharmacol Ther; 2004 Nov; 76(5):441-51. PubMed ID: 15536459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population pharmacokinetic model with time-dependent covariates measured with errors.
    Li L; Lin X; Brown MB; Gupta S; Lee KH
    Biometrics; 2004 Jun; 60(2):451-60. PubMed ID: 15180671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption.
    Alimpertis N; Tsekouras AA; Macheras P
    Pharm Res; 2023 Sep; 40(9):2167-2175. PubMed ID: 37537424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nonlinearities and uncorrelated or correlated errors in realistic simulated data on the prediction abilities of augmented classical least squares and partial least squares.
    Melgaard DK; Haaland DM
    Appl Spectrosc; 2004 Sep; 58(9):1065-73. PubMed ID: 15479523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: Part II. Non-linear kinetics.
    Fernández-Teruel C; Gonzalez-Alvarez I; Navarro-Fontestad C; García-Arieta A; Bermejo M; Casabó VG
    Eur J Pharm Sci; 2009 Jan; 36(1):147-56. PubMed ID: 19038335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonlinear regression model-based predictive control algorithm.
    Dubay R; Abu-Ayyad M; Hernandez JM
    ISA Trans; 2009 Apr; 48(2):180-9. PubMed ID: 19144334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of pharmacokinetic systems using stochastic deconvolution.
    Kakhi M; Chittenden J
    J Pharm Sci; 2013 Dec; 102(12):4433-43. PubMed ID: 24174399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparsity enhancement for blind deconvolution of ultrasonic signals in nondestructive testing application.
    Wei L; Hua-ming L; Pei-wen Q
    Rev Sci Instrum; 2008 Jan; 79(1):014901. PubMed ID: 18248057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.